Hyder SM - Search Results

1

Re-activation of the p53 pathway inhibits in vivo and in vitro growth of hormone-dependent human breast cancer cells.

Liang Y, Besch-Williford C, Benakanakere I, Hyder SM. Liang Y, et al. Among authors: hyder sm. Int J Oncol. 2007 Oct;31(4):777-84. Int J Oncol. 2007. PMID: 17786308

2

Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects.

Liang Y, Hyder SM. Liang Y, et al. Among authors: hyder sm. Endocrinology. 2005 Aug;146(8):3632-41. doi: 10.1210/en.2005-0103. Epub 2005 Apr 21. Endocrinology. 2005. PMID: 15845615

3

p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.

Liang Y, Wu J, Stancel GM, Hyder SM. Liang Y, et al. Among authors: hyder sm. J Steroid Biochem Mol Biol. 2005 Feb;93(2-5):173-82. doi: 10.1016/j.jsbmb.2004.12.011. Epub 2005 Jan 28. J Steroid Biochem Mol Biol. 2005. PMID: 15860260

4

Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.

Wu J, Liang Y, Nawaz Z, Hyder SM. Wu J, et al. Among authors: hyder sm. Int J Oncol. 2005 Dec;27(6):1647-59. Int J Oncol. 2005. PMID: 16273221

5

Vascular endothelial growth factor induces proliferation of breast cancer cells and inhibits the anti-proliferative activity of anti-hormones.

Liang Y, Brekken RA, Hyder SM. Liang Y, et al. Among authors: hyder sm. Endocr Relat Cancer. 2006 Sep;13(3):905-19. doi: 10.1677/erc.1.01221. Endocr Relat Cancer. 2006. PMID: 16954439

6

Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.

Liang Y, Besch-Williford C, Brekken RA, Hyder SM. Liang Y, et al. Among authors: hyder sm. Cancer Res. 2007 Oct 15;67(20):9929-36. doi: 10.1158/0008-5472.CAN-07-1103. Cancer Res. 2007. PMID: 17942925

7

Regression of progestin-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors in Sprague-Dawley rats by p53 reactivation and induction of massive apoptosis: a pilot study.

Benakanakere I, Besch-Williford C, Ellersieck MR, Hyder SM. Benakanakere I, et al. Among authors: hyder sm. Endocr Relat Cancer. 2009 Mar;16(1):85-98. doi: 10.1677/ERC-08-0069. Epub 2008 Dec 15. Endocr Relat Cancer. 2009. PMID: 19075036

8

Estrogen regulation of thrombospondin-1 in human breast cancer cells.

Hyder SM, Liang Y, Wu J. Hyder SM, et al. Int J Cancer. 2009 Sep 1;125(5):1045-53. doi: 10.1002/ijc.24373. Int J Cancer. 2009. PMID: 19391135 Free PMC article.

9

Regulation of thrombospondin-1 by natural and synthetic progestins in human breast cancer cells.

Hyder SM, Liang Y, Wu J, Welbern V. Hyder SM, et al. Endocr Relat Cancer. 2009 Sep;16(3):809-17. doi: 10.1677/ERC-08-0311. Epub 2009 Jul 1. Endocr Relat Cancer. 2009. PMID: 19570906

10

PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein.

Liang Y, Besch-Williford C, Hyder SM. Liang Y, et al. Among authors: hyder sm. Int J Oncol. 2009 Nov;35(5):1015-23. doi: 10.3892/ijo_00000416. Int J Oncol. 2009. PMID: 19787255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters